Table 4.
Cancer Type | 1995-1999 | 2000-2004 | ||||
---|---|---|---|---|---|---|
| ||||||
SEP 1c | SEP 5d | SRR (95% CI)e | SEP 1c | SEP 5d | SRR (95% CI)e | |
All sites | 87.9 | 94.9 | 0.92 (0.85-1.00) | 83.5 | 91.8 | 0.90 (0.83-0.98) |
Brain and other nervous system | NCf | NCf | NCf | NCf | NCf | NCf |
Breast | 11.6 | 18.2 | 0.63 (0.50-0.79) | 13.0 | 18.5 | 0.70 (0.57-0.85) |
Cervix uteri | NCf | NCf | NCf | 1.8 | 2.3 | 0.81 (0.44-1.37) |
Colon and rectum | 9.8 | 11.3 | 0.86 (0.67-1.10) | 11.5 | 11.3 | 1.01 (0.81-1.26) |
Corpus and uterus, NOS | 3.1 | 3.4 | 0.90 (0.56-1.39) | 4.2 | 3.2 | 1.31 (0.88-1.88) |
Esophagus | 2.9 | 2.0 | 1.43 (0.85-2.29) | 1.8 | 1.0 | 1.76 (0.91-3.16) |
Kidney and renal pelvis | NCf | NCf | NCf | NCf | NCf | NCf |
Larynx | NCf | NCf | NCf | NCf | NCf | NCf |
Leukemia | 2.9 | 3.2 | 0.89 (0.54-1.40) | 2.8 | 3.7 | 0.74 (0.46-1.14) |
Liver and intrahepatic bile duct | 6.7 | 5.0 | 1.33 (0.96-1.81) | 4.5 | 5 | 0.88 (0.61-1.24) |
Lung and bronchus | 9.2 | 9.8 | 0.94 (0.71-1.21) | 9.8 | 9.9 | 0.98 (0.77-1.24) |
Non-Hodgkin lymphoma | 2.3 | 3.7 | 0.62 (0.35-1.01) | 2.2 | 3.2 | 0.68 (0.39-1.09) |
Oral cavity and pharynx | NCf | NCf | NCf | NCf | NCf | NCf |
Pancreas | 4.6 | 5.2 | 0.87 (0.59-1.24) | 3.5 | 4.4 | 0.79 (0.52-1.16) |
Stomach | 7.5 | 4.5 | 1.64 (1.20-2.22) | 5.2 | 4.1 | 1.26 (0.89-1.75) |
Thyroid | NCf | NCf | NCf | NCf | NCf | NCf |
Urinary bladder | NCf | NCf | NCf | NCf | NCf | NCf |
Abbreviations: SRR, standardized rate ratio; CI, confidence interval; NC, not calculated; NOS, not otherwise specified.
Rates are per 100,000 and are age-adjusted to the Census 2000 population for Puerto Rico (12).
See Methods for calculations used to derive SEP scores.
SEP 1 is the lowest socioeconomic position.
SEP 5 is the highest socioeconomic position and is the reference group.
Defined as SEP 1 divided by SEP 5 according to the Tiwari method.
Cell contains <15 cases in 1 of the categories.